Drug Approval | December 27, 2021
Covaxin receives approval for Emergency Use in Children 12-18 years
Covaxin is formulated uniquely such that the same dosage can be administered to adults and children
Covaxin is formulated uniquely such that the same dosage can be administered to adults and children
The Covid-19 At-Home Test uses a simple nasal swab sample to enable individuals to self-test at home and receive accurate, reliable and quick results in as few as 20 minutes for SARS-CoV-2 and all known variants of concern, including Omicron
The Home Healthcare market is expected to be US $ 14.2 by 2025
The authorization provides an additional treatment option against the Covid-19 virus in the form of a pill that can be taken orally
SAGE recommends additional third dose of the vaccine administered to immunocompromised persons
Patient with acute Covid-19 infection treated at BGS Gleneagles Global Hospital
The VaxIT app, developed on the Salesforce platform for Azim Premji Foundation and its partners, captures the status of vaccinations to help individuals plan and stay updated on their progress
First Emergency Use Listing granted by WHO for a protein-based Covid-19 vaccine
2022 is going to be the year of opportunities and innovations from the medical industry in India
The company is now ready to offer clinical testing anywhere in the world after early case studies conducted in Israel have demonstrated recovery within 48 hours
Subscribe To Our Newsletter & Stay Updated
